Relationship between human development and drug use. Human development index and drug use

被引:2
|
作者
Salazar Silva, Fernando [1 ]
Villatoro Velazquez, Jorge Ameth [2 ]
Oliva Robles, Natania Froylan [2 ]
Hynes, Marya
de Marco, Maria
机构
[1] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Lima 31, Peru
[2] Inst Nacl Psiquiat Ramon Fuente Muniz, Mexico City, DF, Mexico
关键词
Human development index; drug use; Latin America;
D O I
10.17711/SM.0185-3325.2014.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Human Development Index is currently considered a reference indicator to account for the social and economic situation experienced by countries. Method This study was conducted using the database from the study "Guiding Elements for Public Policies on Drugs in the Subregion - First Comparative Study on Drug Use and Associated Factors in Population of 15 to 64 years", held in Uruguay, Bolivia, Chile, Peru, Ecuador and Argentina. Target was urban population, from both sexes and of 12 to 65 years. Samples were stratified, three-staged and probabilistic. Sample sizes were theoretical with the inclusion of a non-response rate. Results Prevalence of drug consumption during last year and last month prior to the survey is higher in countries with high HDI compared with medium HDI countries. Lifetime prevalence of alcohol consumption is higher in countries with medium HDI compared with those with high HDI. There is less consumption in lifetime prevalence of legal drugs of countries with higher human development index and an equal rate of cigarette consumption. Discussion High development index implies that the inhabitants of a country have a long and healthy life, more access to knowledge and a decent standard of living. Population with a favorable view on these indicators are not only exposed, but they are also active drug users. The higher the index of human development is, the higher the drug consumption rates are, which indicate that although the human development index can reflect material or economic improvements, it is not necessarily traduced in the human value of the people or society and does not assure quality of life or well-being.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [21] The use of imaging to accelerate drug development
    Aboagye, E
    DRUG DISCOVERY TODAY, 2002, 7 (13) : 706 - 707
  • [22] Use of imaging and genetics in drug development
    Bertolino, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S126 - S126
  • [23] Use of GWAS for Drug Discovery and Development
    Liou, Shyh-Yuh
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2014, 134 (04): : 485 - 490
  • [24] RELATIONSHIP BETWEEN COUNTRY GOVERNANCE INDICATORS AND HUMAN DEVELOPMENT INDEX
    Aguiar Filho, Antonio
    Tome, Marco Antonio
    Farias, Adilson de Brito
    Machado Junior, Celso
    Mantovani Ribeiro, Daiefly Nassif
    GESTAO E DESENVOLVIMENTO, 2019, 16 (01): : 53 - 70
  • [25] The use of radiotracers in drug discovery and development
    Paans, AMJ
    DRUG DISCOVERY TODAY, 2003, 8 (16) : 734 - 734
  • [26] Use of Artificial Intelligence in Drug Development
    Druedahl, Louise C.
    Price II, W. Nicholson
    Minssen, Timo
    Sarpatwari, Ameet
    JAMA NETWORK OPEN, 2024, 7 (05) : E2414139
  • [27] The use of skin models in drug development
    Mathes, Stephanie H.
    Ruffner, Heinz
    Graf-Hausner, Ursula
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 81 - 102
  • [28] The Use of Mobile Technology in Drug Development
    Mehta, Neha
    Wang, Jian
    Wang, Yaning
    Zhu, Hao
    Liu, Qi
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 706 - 709
  • [29] The use of population pharmacokinetics in drug development
    Vozeh, S
    Steimer, JL
    Rowland, M
    Morselli, P
    Mentre, F
    Balant, LP
    Aarons, L
    CLINICAL PHARMACOKINETICS, 1996, 30 (02) : 81 - 93
  • [30] HUMAN METABOLIC DATABASES FOR DRUG DEVELOPMENT AND DRUG INTERACTIONS
    Ciloy, Jose Martin
    Kitajima, Masato
    Sakamaki, Takako
    Pawlak, Jaroslaw
    Rendic, Slobodan Petar
    DRUG METABOLISM REVIEWS, 2007, 39 : 118 - 118